Bath Savings Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
15,646
+730
+5% +$19.1K 0.04% 142
2026
Q1
$419K Sell
14,916
-986
-6% -$26.3K 0.04% 133
2025
Q4
$396K Buy
15,902
+1,336
+9% +$33.7K 0.04% 137
2025
Q3
$371K Sell
14,566
-520
-3% -$12.8K 0.04% 135
2025
Q2
$366K Sell
15,086
-300
-2% -$7K 0.04% 133
2025
Q1
$390K Sell
15,386
-27,842
-64% -$729K 0.04% 126
2024
Q4
$1.15M Sell
43,228
-160
-0.4% -$4.34K 0.12% 92
2024
Q3
$1.26M Sell
43,388
-1,144
-3% -$33.4K 0.12% 88
2024
Q2
$1.25M Sell
44,532
-1,288
-3% -$35.5K 0.13% 88
2024
Q1
$1.27M Buy
45,820
+4,205
+10% +$117K 0.14% 90
2023
Q4
$1.2M Sell
41,615
-852
-2% -$25.8K 0.13% 91
2023
Q3
$1.41M Sell
42,467
-534
-1% -$18.9K 0.17% 83
2023
Q2
$1.58M Sell
43,001
-731
-2% -$28.5K 0.18% 85
2023
Q1
$1.78M Sell
43,732
-1,565
-3% -$67.6K 0.22% 73
2022
Q4
$2.32M Buy
45,297
+78
+0.2% +$3.74K 0.3% 67
2022
Q3
$1.98M Buy
45,219
+118
+0.3% +$5.73K 0.28% 69
2022
Q2
$2.37M Sell
45,101
-113
-0.2% -$5.76K 0.31% 67
2022
Q1
$2.34M Buy
45,214
+5,530
+14% +$287K 0.27% 69
2021
Q4
$2.34M Buy
39,684
+200
+0.5% +$9.91K 0.24% 69
2021
Q3
$1.7M Sell
39,484
-362
-0.9% -$16K 0.2% 74
2021
Q2
$1.56M Sell
39,846
-994
-2% -$38.7K 0.18% 78
2021
Q1
$1.48M Buy
40,840
+18,658
+84% +$662K 0.19% 78
2020
Q4
$817K Buy
22,182
+1,744
+9% +$64K 0.11% 87
2020
Q3
$712K Buy
20,438
+874
+4% +$30.6K 0.12% 82
2020
Q2
$607K Sell
19,564
-408
-2% -$13.9K 0.11% 82
2020
Q1
$618K Hold
19,972
0.13% 75
2019
Q4
$743K Buy
19,972
+2,883
+17% +$103K 0.13% 77
2019
Q3
$583K Sell
17,089
-1,058
-6% -$38.5K 0.11% 81
2019
Q2
$746K Buy
18,147
+595
+3% +$23.6K 0.15% 72
2019
Q1
$708K Sell
17,552
-316
-2% -$12.7K 0.15% 72
2018
Q4
$740K Buy
17,868
+472
+3% +$19.6K 0.18% 72
2018
Q3
$727K Sell
17,396
-106
-0.6% -$4.08K 0.16% 76
2018
Q2
$603K Sell
17,502
-2,017
-10% -$68.9K 0.14% 86
2018
Q1
$657K Sell
19,519
-393
-2% -$13.5K 0.16% 82
2017
Q4
$684K Buy
19,912
+780
+4% +$26.6K 0.17% 83
2017
Q3
$648K Sell
19,132
-163
-0.8% -$5.24K 0.17% 84
2017
Q2
$615K Buy
19,295
+479
+3% +$15.1K 0.17% 83
2017
Q1
$611K Sell
18,816
-347
-2% -$10.9K 0.18% 83
2016
Q4
$590K Buy
19,163
+106
+0.6% +$3.24K 0.18% 86
2016
Q3
$613K Buy
19,057
+1,111
+6% +$37.1K 0.19% 84
2016
Q2
$599K Sell
17,946
-3,094
-15% -$98.7K 0.19% 78
2016
Q1
$592K Buy
21,040
+1,382
+7% +$39.5K 0.19% 80
2015
Q4
$602K Buy
19,658
+258
+1% +$8.12K 0.2% 82
2015
Q3
$578K Sell
19,400
-634
-3% -$20.3K 0.2% 80
2015
Q2
$637K Sell
20,034
-3,506
-15% -$114K 0.22% 76
2015
Q1
$777K Sell
23,540
-4,216
-15% -$134K 0.26% 73
2014
Q4
$820K Buy
27,756
+422
+2% +$12.1K 0.28% 71
2014
Q3
$767K Hold
27,334
0.29% 67
2014
Q2
$769K Buy
27,334
+2,002
+8% +$57.1K 0.29% 66
2014
Q1
$772K Buy
25,332
+633
+3% +$18.9K 0.31% 65
2013
Q4
$718K Buy
24,699
+2,383
+11% +$69.4K 0.29% 66
2013
Q3
$608K Buy
22,316
+7,171
+47% +$195K 0.27% 70
2013
Q2
$403K Buy
+15,145
New +$418K 0.19% 80

Other funds holding PFE

Bath Savings Trust's PFE Position: Q2 2026 in Review

Bath Savings Trust increased its Pfizer (PFE) stake by 4.9% in Q2 2026, buying an estimated $19.1K and bringing the position to 15,646 shares worth $377K. The position accounts for 0.04% of the portfolio, ranked #142.

Bath Savings Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.37M in Q2 2022. 676 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bath Savings Trust held 15,646 shares of Pfizer worth $377K as of Q2 2026.
  • Bath Savings Trust bought 730 Pfizer shares in Q2 2026, an estimated $19.1K.
  • Pfizer made up 0.04% of Bath Savings Trust's portfolio in Q2 2026, its #142 holding.
  • Bath Savings Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Bath Savings Trust's Pfizer position peaked at $2.37M in Q2 2022.
  • 676 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.